Post-COVID Lung Damage: Why You Still Cannot Breathe Months After Recovery
Millions of people recovered from COVID-19 but never fully got their breath back. Fatigue, chest tightness, breathlessness, and a cough that will not go away — these are not imagined. A pulmonologist explains what COVID does to the lungs, what long COVID means, and how to reclaim your respiratory health.
They come into my clinic looking frustrated and a little embarrassed — as if they feel they should not still be unwell. "I had COVID more than six months ago," they say. "Everyone else recovered. Why am I still breathless?" Or: "The doctors say my tests are normal. But I cannot climb stairs without stopping. I cannot play with my children. Something is wrong."
Something is wrong. And it is not imagined, not psychological weakness, and not a sign of poor fitness. Post-COVID lung involvement is a real, well-documented, physiologically explainable phenomenon that affects a significant proportion of people who contracted SARS-CoV-2 — including many who had what appeared to be a mild infection at the time. The frustration these patients carry is compounded by the fact that standard tests often appear reassuringly normal even when genuine functional impairment exists.
As a pulmonologist who has assessed and managed post-COVID respiratory patients since the pandemic began, I want to give you a clear, honest, and comprehensive picture of what COVID does to the lungs — both during the acute infection and in the months that follow — and what can be done to support recovery.
What COVID-19 Does to the Lungs During Acute Infection
To understand post-COVID lung problems, it helps to first understand what SARS-CoV-2 — the virus that causes COVID-19 — actually does to lung tissue during the acute infection. The damage it causes is not uniform. It varies enormously in extent and character between patients, which is one of the reasons post-COVID lung presentations are so varied.
The Entry Point — ACE2 Receptors
SARS-CoV-2 enters the body by binding to a receptor called ACE2, which is found throughout the respiratory tract but is particularly abundant on the cells lining the alveoli — the tiny air sacs deep in the lungs where oxygen crosses into the bloodstream. This distribution explains why COVID-19 so frequently causes lower respiratory tract involvement and why its effects on oxygen transfer are so significant in serious cases.
Direct Viral Damage
The virus infects and destroys the type II pneumocytes — the specialised cells lining the alveoli that produce surfactant, the substance that prevents the air sacs from collapsing. Loss of these cells destabilises the alveoli, impairs gas exchange, and triggers the cascade of inflammatory events that characterises severe COVID pneumonia.
The Inflammatory Storm
In a significant proportion of patients — particularly those with more severe disease — the immune response to the virus becomes dysregulated, producing an excessive inflammatory reaction sometimes called a cytokine storm. This immune overreaction causes diffuse damage to the alveolar lining far beyond the areas directly infected by the virus. The resulting condition — diffuse alveolar damage — is the pathological basis of the most serious COVID pneumonia and is associated with the ground-glass opacities seen on CT scanning.
Microclots and Vascular Damage
One of the most distinctive features of COVID-19 — distinguishing it from most other respiratory viral infections — is its profound effect on the blood vessels. SARS-CoV-2 directly infects and damages the endothelial cells lining the tiny blood vessels of the lungs, triggering inflammation and widespread microclot formation. These microclots impair blood flow through the pulmonary capillaries — the vessels where oxygen crosses from the air sacs into the blood — even in areas where the air sacs themselves appear relatively unaffected. This vascular damage contributes significantly to the low oxygen levels seen in COVID patients and is an important driver of persistent breathlessness after recovery.
Fibrotic Scarring
In the aftermath of severe alveolar damage, the lung attempts to repair itself. In some patients — particularly those with prolonged severe disease — this repair process is dysregulated, laying down excessive fibrous scar tissue rather than regenerating normal alveolar architecture. This post-COVID fibrosis stiffens the lungs, reduces their capacity, and impairs oxygen transfer — sometimes producing a picture similar to pulmonary fibrosis that may persist for months or, in some patients, indefinitely.
What Is Long COVID? Defining the Condition
Long COVID — formally termed Post-Acute Sequelae of SARS-CoV-2 infection (PASC) — is defined by the World Health Organisation as symptoms that persist or develop after three months from the onset of COVID-19 infection, last for at least two months, and cannot be explained by an alternative diagnosis. It is not a single condition but a cluster of overlapping syndromes affecting multiple organ systems — with respiratory symptoms being among the most common and most disabling.
Critically, long COVID is not confined to those who had severe acute illness. Research consistently shows that a significant proportion of long COVID patients — perhaps the majority — had what appeared to be mild COVID at the time, did not require hospitalisation, and were not considered at high risk. The severity of the acute infection does not reliably predict who will develop persistent symptoms.
Long COVID also does not discriminate by age or fitness. Elite athletes, young adults, and previously healthy individuals with no prior medical conditions are among those most visibly and puzzlingly affected — people for whom persistent breathlessness after a "mild" respiratory illness seems most incongruous and least explainable within their prior understanding of their own health.
Post-COVID Respiratory Symptoms: What Patients Experience
The respiratory manifestations of long COVID are diverse, and understanding what they feel like from the patient's perspective is important for recognising them accurately.
The most common respiratory complaint. Patients describe breathlessness that is disproportionate to their level of exertion — climbing stairs, walking to the shops, or simply getting dressed leaves them more breathless than before COVID. This often coexists with a sense of not being able to take a satisfying deep breath.
A particularly distressing symptom in which patients feel they cannot inhale fully — as if there is a ceiling on how deep a breath they can take. This often reflects a breathing pattern disorder or chest wall restriction rather than measurable lung capacity reduction, but is nonetheless physiologically real and genuinely debilitating.
A dry, irritating cough — often worse with talking, laughing, or changes in temperature — that persists for weeks to months after the acute infection has resolved. In some patients it reflects ongoing airway inflammation; in others, post-nasal drip or laryngeal sensitivity triggered by the infection.
Persistent chest tightness — often described as a band around the chest or a heaviness — and intermittent chest pain are common post-COVID complaints. They may reflect ongoing pleuritic inflammation, musculoskeletal changes from prolonged coughing, or airway hypersensitivity triggered by the infection.
A characteristic feature of long COVID — symptoms that worsen significantly 24 to 72 hours after physical or mental exertion, far out of proportion to the activity performed. Patients describe feeling "crashed" after a walk that should have been manageable. This pattern distinguishes long COVID fatigue from ordinary deconditioning.
Many post-COVID patients experience breathlessness that is accompanied or worsened by "brain fog" — difficulty concentrating, word-finding difficulties, and memory lapses. The co-occurrence of cognitive and respiratory symptoms reflects the multi-system nature of long COVID and should be assessed holistically.
The post-COVID patients who stay with me most are the ones who were told, repeatedly, that their tests are normal and they should be feeling better by now. Their distress is not just physical — it is the distress of not being believed. These symptoms are real. The mechanisms driving them are increasingly well understood. And the path to recovery, while gradual, is navigable with the right specialist support.
— Dr. Nabila Zaheer, Pulmonologist
The Mechanisms Behind Persistent Symptoms
One of the reasons post-COVID respiratory symptoms are so often dismissed — by both patients and sometimes clinicians — is that standard tests frequently appear normal. Spirometry may be within the normal range. Chest X-rays often look clear. Oxygen saturation at rest may be 98 percent. And yet the patient is genuinely, functionally limited. Understanding why this happens requires looking at several less conventional physiological mechanisms.
Breathing Pattern Disorder
A significant proportion of post-COVID breathlessness — particularly the sensation of incomplete breath and breathlessness disproportionate to exertion — is driven not by structural lung damage but by a disordered breathing pattern acquired during or after the acute illness. The experience of breathlessness during COVID — combined sometimes with anxiety about breathing and the physiological impact of prolonged illness — recalibrates the brain's respiratory control centres, producing an abnormal breathing pattern that perpetuates breathlessness even after the underlying infection has resolved. This is a real physiological phenomenon — not "all in the mind" — and it responds well to targeted respiratory physiotherapy.
Reduced Gas Transfer Efficiency
Even when spirometry is normal — measuring the volume and flow of air — the efficiency with which oxygen crosses from the air sacs into the blood may be reduced. A test called the diffusing capacity for carbon monoxide (DLCO) specifically measures this gas transfer function and is abnormal in a significant proportion of post-COVID patients who have normal spirometry. DLCO reduction reflects residual alveolar damage or vascular impairment that affects oxygen transfer without necessarily affecting lung volumes — explaining why patients are breathless despite "normal" standard tests.
Autonomic Dysfunction
COVID-19 appears to affect the autonomic nervous system — the network of nerves that regulates heart rate, blood pressure, and breathing rate automatically. Post-COVID autonomic dysfunction — sometimes called dysautonomia — can cause abnormal heart rate responses to exertion (postural orthostatic tachycardia syndrome, or POTS), inappropriate breathlessness during activity, and exercise intolerance that far exceeds what would be expected from lung function measurements alone.
Residual Pulmonary Inflammation and Fibrosis
In patients who had more severe COVID pneumonia — particularly those who required hospitalisation, supplemental oxygen, or intensive care — residual ground-glass opacities and early fibrotic changes on CT scanning are common at three and six months post-discharge. In many patients these changes resolve gradually over 12 to 24 months. In others — particularly those with extensive initial disease — some degree of permanent structural change persists, with corresponding functional impairment.
Deconditioning
Prolonged illness, bed rest, and reduced physical activity during and after acute COVID inevitably cause deconditioning — reduction in cardiovascular and muscular fitness that independently worsens breathlessness during exertion. Deconditioning is not the primary cause of post-COVID breathlessness in most patients, but it is an important contributing factor that, crucially, responds well to structured rehabilitation.
How Post-COVID Lung Problems Are Assessed
A thorough post-COVID respiratory assessment goes beyond standard spirometry and a chest X-ray. The appropriate investigations depend on the severity of the initial illness, the nature of current symptoms, and the time elapsed since the acute infection.
Pulmonary Function Tests Including DLCO
A full set of pulmonary function tests — including spirometry, lung volumes, and diffusing capacity (DLCO) — provides a comprehensive picture of lung function that standard spirometry alone cannot. DLCO is particularly important in post-COVID assessment and is frequently abnormal when spirometry appears normal.
High-Resolution CT Scan
In patients who had moderate to severe COVID or who have significant ongoing symptoms, a chest HRCT provides detailed information about the presence and extent of residual ground-glass opacities, organising pneumonia, or early fibrotic changes. It is the most sensitive imaging tool for detecting persistent post-COVID lung abnormalities and guides decisions about the need for further treatment or monitoring.
Six-Minute Walk Test and Cardiopulmonary Exercise Testing
A six-minute walk test measures functional exercise capacity in a standardised, reproducible way — revealing exercise limitations that do not appear at rest. In patients whose symptoms seem disproportionate to resting measurements, cardiopulmonary exercise testing (CPET) — which simultaneously monitors breathing, heart function, and gas exchange during progressive exercise — provides the most detailed picture of exercise limitation and its mechanism, guiding targeted rehabilitation.
Echocardiogram
COVID-19 can affect the heart as well as the lungs — causing myocarditis, pericarditis, or pulmonary hypertension secondary to vascular damage. An echocardiogram assesses cardiac function and pulmonary artery pressures, and is indicated in post-COVID patients with significant breathlessness, reduced exercise tolerance, or evidence of right heart strain.
Assessment for Breathing Pattern Disorder
Clinical assessment of breathing pattern — observing the patient's breathing mechanics at rest and during exertion — identifies disordered breathing patterns that respond to physiotherapy. Questionnaires such as the Nijmegen Questionnaire help quantify the contribution of breathing pattern disorder to reported symptoms.
Recovery and Rehabilitation: What Helps
Post-COVID respiratory recovery is possible for the majority of patients — but it is rarely linear, rarely rapid, and rarely achieved without structured support. The following evidence-based approaches form the core of post-COVID pulmonary rehabilitation.
For patients with breathing pattern disorder — which underlies a significant proportion of post-COVID breathlessness — respiratory physiotherapy is the most effective treatment available. A physiotherapist trained in breathing pattern disorders teaches the patient to recognise their disordered breathing pattern, retrain the diaphragm and accessory breathing muscles, slow and deepen the breathing cycle, and reduce the anxiety around breathlessness that perpetuates the pattern. Most patients with breathing pattern disorder notice significant improvement within six to eight weeks of consistent practice. This should be the first line of post-COVID respiratory rehabilitation in all patients.
Exercise rehabilitation improves functional capacity, reduces breathlessness during exertion, combats deconditioning, and improves mood and quality of life in post-COVID patients. However, the approach must be carefully paced — particularly in patients with post-exertional malaise, where pushing too hard too soon reliably causes symptom flares. The principle is "start low, go slow" — beginning at a level well within current capacity and increasing gradually over weeks to months, guided by symptom response. Formal pulmonary rehabilitation programmes, where available, provide the safest and most effective framework.
In patients with confirmed organising pneumonia on HRCT — a pattern of post-inflammatory consolidation that can follow COVID pneumonia — a course of oral corticosteroids often produces dramatic improvement. This is one of the most satisfying treatments in post-COVID medicine: patients who have been significantly limited for months frequently notice substantial improvement within two to four weeks of starting steroids. The decision to prescribe steroids requires radiological confirmation of the appropriate pattern and specialist assessment — it is not appropriate for all post-COVID presentations.
COVID appears capable of triggering or unmasking a range of conditions that independently cause breathlessness and require their own specific management. These include new-onset asthma (COVID-triggered airway hypersensitivity responding to inhaled corticosteroids), new-onset atrial fibrillation (irregular heart rhythm causing breathlessness), POTS (autonomic dysfunction responding to specific physical rehabilitation and sometimes medication), and new-onset vocal cord dysfunction (laryngeal breathing disorder responding to voice therapy). Identifying and treating these specific conditions — rather than attributing everything non-specifically to "long COVID" — produces far better outcomes.
Adequate nutrition supports immune recovery, muscle rebuilding, and the energy demands of rehabilitation. Many post-COVID patients have reduced appetite and have lost weight during their illness. High-protein intake, vitamin D supplementation (COVID is associated with vitamin D depletion, and deficiency worsens recovery), and iron supplementation where deficiency is confirmed all support recovery. Sleep quality — often severely disrupted after COVID — directly affects fatigue, immune function, and exercise capacity, and should be specifically addressed as part of post-COVID care.
The psychological burden of long COVID — the uncertainty, the loss of function, the frustration of not being believed, the anxiety about whether recovery is possible — is substantial and deserves direct attention. Anxiety and depression worsen breathlessness, reduce exercise tolerance, and impair rehabilitation outcomes. Cognitive behavioural therapy (CBT), mindfulness-based approaches, and peer support groups all have evidence of benefit. This is not to suggest that the symptoms are psychological in origin — they are not — but to acknowledge that psychological wellbeing and physical recovery are inseparable in post-COVID rehabilitation.
Post-COVID lung recovery is a process, not an event. Serial monitoring of lung function, symptoms, and CT findings over months allows the trajectory of recovery to be tracked, treatment to be adjusted as needed, and complications to be identified early. Patients with significant residual abnormalities at three months should be reviewed again at six and twelve months. Those with suspected fibrotic change require longer-term monitoring and, in some cases, consideration of antifibrotic therapy. A single normal spirometry result does not provide the reassurance that a full serial assessment does.
When to Seek Specialist Pulmonology Assessment
Not every post-COVID patient needs specialist pulmonology review. Mild, improving symptoms in otherwise healthy individuals who had mild COVID may resolve with time and self-directed rehabilitation. However, specialist assessment is strongly indicated in the following circumstances:
- Breathlessness or other respiratory symptoms persisting beyond 12 weeks after COVID recovery
- Symptoms that are not improving — or are worsening — over time
- Oxygen saturation dropping during exercise or exertion (measurable with a pulse oximeter)
- Hospitalisation during the acute COVID illness, particularly if supplemental oxygen or intensive care was required
- Abnormal findings on a chest X-ray or CT scan performed during or after the acute illness
- New symptoms — cough, wheeze, chest tightness — that were not present before COVID
- Significant functional limitation — inability to perform activities that were previously manageable
- Coexisting conditions such as asthma, COPD, heart disease, or diabetes that may interact with post-COVID recovery
Recovery from post-COVID lung involvement is real — I see it happen in my clinic every week. But it rarely happens on its own, and it rarely happens quickly. The patients who recover best are those who get a proper assessment, understand what is driving their symptoms, follow a structured rehabilitation plan, and have the patience to measure their progress in months rather than weeks. The lungs are resilient. They need time, support, and the right guidance to heal.
— Dr. Nabila Zaheer, Pulmonologist
Frequently Asked Questions
I had mild COVID and was never hospitalised. Can I still have lung damage?
Yes — and this surprises many patients. Studies have shown CT abnormalities and reduced DLCO in patients who had mild COVID managed entirely at home. The severity of the acute illness does not reliably predict the presence or degree of persistent lung involvement. If you have respiratory symptoms lasting more than 12 weeks after COVID — regardless of how mild your initial illness seemed — a specialist assessment is warranted. Do not dismiss your symptoms simply because you were not hospitalised.
How long does post-COVID breathlessness last?
This varies considerably between patients and depends on the underlying mechanism. Breathing pattern disorder — with appropriate physiotherapy — typically improves within six to twelve weeks. Organising pneumonia treated with steroids often resolves within two to three months. Residual ground-glass opacities from COVID pneumonia continue to improve for up to 12 to 24 months in most patients. Fibrotic changes, where present, may be more persistent. The trajectory is important — symptoms that are gradually improving, even slowly, carry a better prognosis than those that are static or worsening.
My spirometry was normal but I am still breathless. Does that mean nothing is wrong?
No — absolutely not. Normal spirometry does not exclude significant post-COVID lung involvement. As explained in this article, DLCO reduction — reflecting impaired gas transfer — and breathing pattern disorder both cause genuine breathlessness while leaving spirometry entirely normal. A full pulmonary function test including DLCO, assessment of breathing pattern, and where appropriate cardiopulmonary exercise testing will identify abnormalities that standard spirometry misses. If you have been told your spirometry is normal and dismissed on that basis, please seek a more comprehensive assessment.
Is it safe to exercise with post-COVID breathlessness?
Yes — with the right approach. Exercise is an important part of post-COVID recovery and should not be avoided out of fear. However, the approach must be paced carefully — particularly for patients with post-exertional malaise, where pushing beyond current capacity reliably causes symptom flares. The key principle is to start at a comfortable level and increase very gradually — measuring progress in weeks to months rather than days. Walking, swimming, and cycling at low intensity are good starting points. Formal pulmonary rehabilitation provides the safest, most structured framework. Always discuss exercise with your pulmonologist before starting a rehabilitation programme.
Will my lungs fully recover from COVID?
For the majority of patients — including most of those with moderate COVID pneumonia — the answer is yes, given sufficient time and appropriate rehabilitation. CT abnormalities continue to resolve for up to two years in most patients. Lung function, including DLCO, shows progressive improvement in the majority of cases. Breathing pattern disorder resolves with physiotherapy. However, a minority of patients with extensive initial disease develop persistent fibrotic changes that may not fully resolve. This is precisely why specialist monitoring is important — to identify those who are recovering on the expected trajectory and those who may need additional intervention.
Still Breathless After COVID? You Deserve Answers.
Persistent breathlessness, a cough that will not go away, chest tightness months after recovery — these symptoms deserve a proper specialist assessment, not reassurance that everything is fine. Book a post-COVID pulmonology consultation with Dr. Nabila Zaheer at PulmoCare today.
Book an Appointment